HB 1494

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, providing for over-the-counter availability of ivermectin.

In committee Last action May 21, 2025: Referred to Health

Official bill page and text: palegis.us

Sponsors 11

Prime sponsor: Jacob Banta
Cosponsors (10): David Rowe, David Zimmerman, Jamie Walsh, Joe Hamm, Kathy Rapp, Marla Brown, Rob Kauffman, Tom Jones, Valerie Gaydos, Wendy Fink

Status

In committee as of May 21, 2025. Session ends November 30, 2026; the 2027–2028 session begins in January 2027.

Roll-call votes 0

No roll-call votes recorded for this measure.

Timeline 1

Date	Chamber	Action
May 21, 2025	House	Referred to Health

Data: Open States (API v3; public data, attribution appreciated), updated November 5, 2026. Official record: palegis.us. Bill pages link to the official text, not copied.

Sources for this page

Open States API v3 (Plural Policy): https://v3.openstates.org/ — copied November 2, 2026

Pennsylvania General Assembly: https://www.palegis.us/legislation/bills — copied November 2, 2026

Bill, action and roll-call data from Open States (public data, attribution appreciated). Neither Pennsylvania Capitol Guide nor this information, as presented here, is endorsed by the Pennsylvania General Assembly.